Engineered models of tumor metastasis with immune cell contributions
Summary: Most cancer deaths are due to tumor metastasis rather than the primary tumor. Metastasis is a highly complex and dynamic process that requires orchestration of signaling between the tumor, its local environment, distant tissue sites, and immune system. Animal models of cancer metastasis pro...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2021-03-01
|
| Series: | iScience |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2589004221001474 |
| _version_ | 1819163708833660928 |
|---|---|
| author | Pamela L. Graney Daniel Naveed Tavakol Alan Chramiec Kacey Ronaldson-Bouchard Gordana Vunjak-Novakovic |
| author_facet | Pamela L. Graney Daniel Naveed Tavakol Alan Chramiec Kacey Ronaldson-Bouchard Gordana Vunjak-Novakovic |
| author_sort | Pamela L. Graney |
| collection | DOAJ |
| description | Summary: Most cancer deaths are due to tumor metastasis rather than the primary tumor. Metastasis is a highly complex and dynamic process that requires orchestration of signaling between the tumor, its local environment, distant tissue sites, and immune system. Animal models of cancer metastasis provide the necessary systemic environment but lack control over factors that regulate cancer progression and often do not recapitulate the properties of human cancers. Bioengineered “organs-on-a-chip” that incorporate the primary tumor, metastatic tissue targets, and microfluidic perfusion are now emerging as quantitative human models of tumor metastasis. The ability of these systems to model tumor metastasis in individualized, patient-specific settings makes them uniquely suitable for studies of cancer biology and developmental testing of new treatments. In this review, we focus on human multi-organ platforms that incorporate circulating and tissue-resident immune cells in studies of tumor metastasis. |
| first_indexed | 2024-12-22T17:48:26Z |
| format | Article |
| id | doaj.art-a1d4ce9bdf7d4792b54dc6029a2fa51b |
| institution | Directory Open Access Journal |
| issn | 2589-0042 |
| language | English |
| last_indexed | 2024-12-22T17:48:26Z |
| publishDate | 2021-03-01 |
| publisher | Elsevier |
| record_format | Article |
| series | iScience |
| spelling | doaj.art-a1d4ce9bdf7d4792b54dc6029a2fa51b2022-12-21T18:18:15ZengElsevieriScience2589-00422021-03-01243102179Engineered models of tumor metastasis with immune cell contributionsPamela L. Graney0Daniel Naveed Tavakol1Alan Chramiec2Kacey Ronaldson-Bouchard3Gordana Vunjak-Novakovic4Columbia University, New York, NY 10032, USAColumbia University, New York, NY 10032, USAColumbia University, New York, NY 10032, USAColumbia University, New York, NY 10032, USAColumbia University, New York, NY 10032, USA; Corresponding authorSummary: Most cancer deaths are due to tumor metastasis rather than the primary tumor. Metastasis is a highly complex and dynamic process that requires orchestration of signaling between the tumor, its local environment, distant tissue sites, and immune system. Animal models of cancer metastasis provide the necessary systemic environment but lack control over factors that regulate cancer progression and often do not recapitulate the properties of human cancers. Bioengineered “organs-on-a-chip” that incorporate the primary tumor, metastatic tissue targets, and microfluidic perfusion are now emerging as quantitative human models of tumor metastasis. The ability of these systems to model tumor metastasis in individualized, patient-specific settings makes them uniquely suitable for studies of cancer biology and developmental testing of new treatments. In this review, we focus on human multi-organ platforms that incorporate circulating and tissue-resident immune cells in studies of tumor metastasis.http://www.sciencedirect.com/science/article/pii/S2589004221001474components of the immune systembioengineeringcancerbiochemical assay |
| spellingShingle | Pamela L. Graney Daniel Naveed Tavakol Alan Chramiec Kacey Ronaldson-Bouchard Gordana Vunjak-Novakovic Engineered models of tumor metastasis with immune cell contributions iScience components of the immune system bioengineering cancer biochemical assay |
| title | Engineered models of tumor metastasis with immune cell contributions |
| title_full | Engineered models of tumor metastasis with immune cell contributions |
| title_fullStr | Engineered models of tumor metastasis with immune cell contributions |
| title_full_unstemmed | Engineered models of tumor metastasis with immune cell contributions |
| title_short | Engineered models of tumor metastasis with immune cell contributions |
| title_sort | engineered models of tumor metastasis with immune cell contributions |
| topic | components of the immune system bioengineering cancer biochemical assay |
| url | http://www.sciencedirect.com/science/article/pii/S2589004221001474 |
| work_keys_str_mv | AT pamelalgraney engineeredmodelsoftumormetastasiswithimmunecellcontributions AT danielnaveedtavakol engineeredmodelsoftumormetastasiswithimmunecellcontributions AT alanchramiec engineeredmodelsoftumormetastasiswithimmunecellcontributions AT kaceyronaldsonbouchard engineeredmodelsoftumormetastasiswithimmunecellcontributions AT gordanavunjaknovakovic engineeredmodelsoftumormetastasiswithimmunecellcontributions |